| abstract |
The invention relates to Bicyclic aryl-sulfonic acid [1,3,4]thiadiazol-2-yl-amides of the formula 1 and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta, -alpha and -gamma agonist activity, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system. |